|本期目录/Table of Contents|

[1]艾娟娟,曹克刚,俞丽华,等.偏头痛缓解期基于患者报告的评价量表临床 应用的研究[J].环球中医药,2015,8(05):535-539.[doi:10.3969/j.issn.16741749.2015.05.006]
　AI Juan juan,CAO Ke gang,YU Li hua,et al.Clinical research of migraine pain remission based on patientsreported outcomes[J].,2015,8(05):535-539.[doi:10.3969/j.issn.16741749.2015.05.006]
点击复制

偏头痛缓解期基于患者报告的评价量表临床 应用的研究()
     
分享到：

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第8卷
期数:
2015年05期
页码:
535-539
栏目:
论著
出版日期:
2015-05-06

文章信息/Info

Title:
Clinical research of migraine pain remission based on patientsreported outcomes
作者:
艾娟娟; 曹克刚; 俞丽华; 等
100700 北京中医药大学东直门医院脑病科
Author(s):
AI Juanjuan; CAO Kegang;  YU Lihua;  GAO Ying.
First Department of Gerenal Surgery, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China Corresponding author:GAO Ying, Email:gaoying973@126.com
关键词:
基于患者报告的结局; 偏头痛 ; 量表
Keywords:
Patientsreported outcomes; Migraine pain remission; Scale
分类号:
R7472
DOI:
10.3969/j.issn.16741749.2015.05.006
文献标志码:
A
摘要:
目的进一步验证偏头痛缓解期基于患者报告的结局(Patientsreported outcomes, PRO)评价量表的临床应用。方法采用多中心、前瞻性、随机、双盲、阳性药平行对照研究方法，由15家临床研究中心参加，收集2012年2月至2014年2月符合纳入标准的病例357例，通过EPIDATA数据库录入与管理，二次录入。采用SPSS 16.0进行数据分析，观察其在纳入时，治疗4周、8周、12周及随访时头痛发作次数、天数及PRO量表评分、四个维度评分变化。计数资料描述其频数，采用χ2检验和秩和检验；计量资料采用表示，治疗前后变化采用配对t检验；用相关分析法比较其相关性。结果与基线期比较，治疗4周、8周、12周及随访时头痛发作次数、天数均有改善，差异有统计学意义（P<0.01）；治疗前后PRO量表总分比较有显著性差异（P<0.01）；治疗后PRO量表四个维度与纳入时比较具有显著性差异（P<0.01）；各时点头痛发作天数、发作次数与PRO量表总分的相关系数均＞0.5，呈中等强度相关；与PRO量表头痛情况维度相关系数均＞0.7，呈强相关。结论偏头痛PRO量表可确切反应头痛天数、次数有显著变化的病例，PRO量表可以从多个时点、多个维度较全面科学地反应治疗效果。
Abstract:
ObjectiveThe end of the report further validation based on migraine patients (patients reported outcomes, PRO) evaluation questionnaire of clinical application. Method The multicenter, prospective, randomized, doubleblind, positive drug parallel contrast research method was performed. By 15 clinical research centers, from February 2012 to February 2014, 357 patients in accordance with the inclusion criteria were collected. Data were input and managed by EPIDATA database. SPSS16.0 was used for data analysis. The number of headache attack, days of headache, PRO scale scores, and four dimensions scores were observed at the following time points: before treatment, after treatment for 4, 8 and 12 weeks, followup visit. Chisquare test and ranksum test were used to analyze frequences;Measurement data were expressed as and analyzed using matching t test. Correlation analysis was used to observe the correlation. Result Both the number of headache attack and days of headache were improved after treatment for 4, 8 and 12weeks compared with baseline and there were significant differences (P<0.01). There was significant difference in PRO scale scores before and after treatment (P<0.01); PRO scale four dimensions scores were significant different after treatment in comparison with before treatment(P<0.01). At each time point, correlation coefficient between headache days, attack frequency and PRO scale scores was large than 0.5, with moderate relevant; correlation coefficient between headache days, attack frequency and PRO scale four dimensions scores was larger than 0.7, with strong relevant. Conclusion Migraine PRO scale could exactly reflect patients with significant changes in headache days, the number of attacks, and the PRO scale could imply treatment effect from multiple time points and multiple dimensions.

参考文献/References:

［1］Linde M1, Gustavsson A, Stovner LJ. The cost of headache disorders in Europe: the Eurolight project［J］. Eur J Neurol. 2012, 19(5):703711.
[2]Verrotti A, Bizzarri I, Cecconi G, et al. Headache and comorbidity in pediatric age ［J］. Ital Pediatr, 2014,40(1): 468.
[3]潘飞豹, 周冀英，谭戈. 偏头痛与脑卒中：复杂的关联［J］. 重庆医学, 2013, 42 (22) :2665 2667.
[4]吴静, 陈吉相. 偏头痛与脑白质损害的相关性研究［J］. 中风与神经疾病杂志, 2014，31 (1) : 9 13.
[5]曹阳，余小萍. PＲO量表国内外研究近况［J］. 中医杂志, 2014, 4 (55 ) :710 714.
[6]European Federation of Neurological Societies(EFNS)2006年((EFNS guide］ine on the drug treatment of migraine report 0f an EFNS task Force))、2009年((guideline on the drug treatment of migraine revised report of an EFNS task force)))
[7]胡学军，商洪才，张伯礼. 生存质量及其量表在中医药疗效评价中的应用［J］. 天津中医药，2004，21 ( 3 ) :191 193.
[8]刘砚燕，陈如男，姚静静，等. 患者报告结局的国内外研究进展［J］. 现代预防医学, 2013, 40( 12) : 22682271，2279．
[9]俞丽华,邹忆怀,曹克刚. 偏头痛临床疗效评价现状思考［J］. 中国中医基础医学杂志, 2010, 12（2）:11941195.
[10]俞丽华,邹忆怀,曹克刚. 基于偏头痛患者报告的结局评价量表症状条目初步筛选［J］. 中国全科医学, 2011,14(5B):15351536.
[11]俞丽华,曹克刚. 偏头痛基于患者报告的结局评价量表初稿的研制［J］. 中华中医药学刊, 2014, 32(6):13311334.
[12]曹克刚,孙凡,顾兆一,等. 偏头痛缓解期基于患者报告的结局评价量表的性能考评研究［J］. 世界临床药物, 2014, 35(1):1519.
[13]万崇华, 黄新萍, 常巍, 等. 患者报告的临床结局研究述评［J］. 郑州大学学报, 2011, 46(4):501505.
[14]陈薇，刘建平. 临床疗效研究中的患者报告结局［J］. 中国中西医结合杂志, 2009, 29(8):746749.

相似文献/References:

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（81273688）；国家科技重大专项重大新药创制专项（2009ZX09052028）；北京中医药大学科研创新团队项目(2011CXTD22) 作者单位：100700 北京中医药大学东直门医院脑病科（艾娟娟、曹克刚、高颖）；北京中医药大学第三附属医院急诊科（俞丽华） 作者简介：艾娟娟（1982- ），女，本科，中级。研究方向：中医脑病。Email：15010179928@163.com 通讯作者：高颖（1963- ），女，博士，博士生导师，教授。研究方向：中医脑病。Email：gaoying973@126.com
更新日期/Last Update: 1900-01-01